Alnylam Reports Positive Phase 2 Results In Patisiran Study By: TalkMarkets April 21, 2015 at 21:45 PM EDT Alnylam shares are up about 2% on the news that Patisiran showed substantial efficacy in the phase 2 OLE study Read More >> Related Stocks: Alnylam Pharmaceuticals